flow trial semaglutide results from this major show that reduced the risk of kidney outcomes and FLOW Study Highlights: How Semaglutide

In April 2023, the FDA wrote to the National Association of Boards of Pharmacy, expressing its concerns with the use of salt forms in compounded products

Key Takeaway Managing a weekly injectable medication like Wegovy while traveling is a different kind of challenge from managing daily pills

Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): possible role in hypersensitivity reactions

Despite the benefits, people may face negative attitudes about using drugs for weight loss

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 2326 October 2023

Tamiflu can reduce complications of the flu (such as pneumonia) by 44%, and the risk of hospitalization by 63% when taken in the first 48 hours after contracting the virus, according to the makers of Tamiflu